(Q39300277)

10 September 2017

1 reference

title

Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia (English)

2 references

10 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A43842

5 April 2022

Relationship of the Actions of Neuroleptic Drugs to the Pathophysiology of Tardive Dyskinesia (English)

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

1 reference

1 reference

R. J. Baldessarini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A43842

5 April 2022

D. Tarsy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A43842

5 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=43842

5 April 2022

publication date

1 January 1979

1 reference

International Review of Neurobiology

10 September 2017

published in

1 reference

10 September 2017

volume

21

1 reference

10 September 2017

page(s)

1-45

1 reference

Growth of Pulmonary Alveolar Macrophages in vitro

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Physostigmine effects on phenothiazine-induced extrapyramidal reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dyskinesia with thiothixene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Evidence for dopamine receptor stimulation by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Tardive Dyskinesia: An Evaluation of the Etiologic Association with Neuroleptic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

1 reference

7 January 2021

Prolonged apomorphine-like behavioural effects of apomorphine esters

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The effects of phenothiazines on endocrine function: I. Patients with inappropriate lactation and amenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Central dopamine turnover in schizophrenic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Interaction of atropine-like drugs with dopamine-containing neurones in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Brain homovanillic acid: Regional changes over time with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine receptor binding in the corpus striatum of mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Effects of 5-hydroxytryptophan, oxotremorine, and tetrahydroaminoacridine on apomorphine-induced stereotypy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine-sensitive adenylyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Paradoxical response to dopamine agonists in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Neuropathological investigation of 28 brains from patients with dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Behavioural correlates of modified dopaminergic/anticholinergic responses following chronic treatment with neuroleptic agents of differing activity spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

1 reference

7 January 2021

Persistent Dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Clinical psychopharmacology in its 20th year. Late, unanticipated effects of neuroleptics may limit their use in psychiatry.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine receptors and average clinical doses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Choline chloride in animal models of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Various enzymes involved with putative neurotransmitters. Regional distribution in the brain of deceased mentally normal, chronic schizophrenics or organic brain syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Chronic involuntary movements induced by phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Cholinergic-anticholinergic antagonism in parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Huntington's chorea. Changes in neurotransmitter receptors in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Sensitivity to haloperidol of caudate neurones excited by nigral stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Enhanced sensitivity of caudate neurones to microiontophoretic injections of dopamine in 6-hydroxydopamine treated cats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

High-dose treatment of rats with perphenazine enanthate

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and α-methyl-p-tyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine-Sensitive Adenylate Cyclase: Location in Substantia Nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Feedback loop or output pathway in striato-nigral fibres?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Release of dopamine from dendrites in rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The effect of central nervous system stimulants on tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Self-inhibition by Dopaminergic Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Oral choline administration to patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Haloperidol-induced tardive dyskinesia in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Axonal regeneration and functional plasticity in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Modification of certain central nervous effects of haloperidol during long-term treatment in the mouse and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Amphetamine-induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Immunohistochemical localization of choline acetyltransferase containing neostriatal neurons and their relationship with dopaminergic synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Catecholamine-sensitive adenylate cyclases in nervous tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Tardive and withdrawal dyskinesia associated with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Changes in neostriatal da metabolism after carbachol or atropine microinjections into the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Oxotremorine- and atropine-induced changes of dopamine metabolism in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Evidence for regenerative axon sprouting of central catecholamine neurons in the rat mesencephalon following electrolytic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Therapeutic approaches to tardive dyskinesia. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Mesolimbic dopamine neurons: Effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The pharmacology of tardive dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

An experimental model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Central cholinergic-anticholinergic antagonism in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Effect of cholinergic and anticholinergic agents on tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The effect of lithium on an animal model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Pathophysiology of drug-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine release in substantia nigra?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Sodium valproate in chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Evidence for glutamic acid decarboxylase-containing interneurons in the neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Possible changes in striatal and limbic cholinergic systems in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Neostriatal choline acetylase and cholinesterase following selective brain lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Aging and Extrapyramidal Function

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dextroamphetamine-Sulfate-Induced Dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Acute dystonia as an idiosyncratic response to neuroleptics in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Pharmacology of neuroleptics upon repeated administration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopaminergic supersensitivity after neuroleptics: Time-course and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Long-term behavioural and biochemical effects following prolonged treatment with a neuroleptic drug (flupenthixol) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Effect of drugs used in psychoses on cerebral dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Increased dopamine-receptor sensitivity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Increased cyclic AMP response to norepinephrine in the rat brain following 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Tardive Dyskinesia as a Possible Sequel of Long-Term Therapy with Phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Biochemical effects in man and rat of three drugs which can increase brain GABA content

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Morpho-histochemical study of the action of trifluoperazine on the brain of white rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

α-Flupenthixol-induced hyperactivity by chronic dosing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Adrenergic Effect of Chronic Administration of Neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Persistent dyskinesias following phenothiazine therapy. Report of five cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

REORGANIZATION OF FUNCTION IN THE NERVOUS SYSTEM--USE AND DISUSE.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Huntington's disease: Treatment with dipropylacetic acid and gamma-aminobutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Binding of α- and β-adrenergic ligands to cerebral cortical membranes: Effect of 6-hydroxydopamine treatment and relationship to the responsiveness of cyclic AMP-generating systems in two rat strains

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Contractual agreements with adolescents?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Neuronal hyposensitivity to dopamine in the caudate nucleus depleted of biogenic amines by tegmental lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

An anatomy of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Sodium valproate in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

A neuroendocrine study of supersensitivity in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Pharmacologically Induced Behavioural Supersensitivity to Apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Deanol Acetamidobenzoate Treatment in Choreiform Movement Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Physostigmine in choreiform movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Rotational behavior induced in rats by intranigral picrotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Involvement of brain cholinergic mechanisms in the action of chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Clozapine: reduction of the initial dopamine turnover increase by repeated treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dyskinesias Evoked in Monkeys by Weekly Administration of Haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Supersensitivity of caudate neurones after repeated administration of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

Dopamine receptor blockade--a central action of chlorpromazine on striatal neurones.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960636-4

7 January 2021

44

120

215

Castaigne

1969

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

Biological Psychiatry

50

10

227

Colon

1975

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

The New England Journal of Medicine

5 April 2022

69

293

152

Davis

1975

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

The New England Journal of Medicine

5 April 2022

121

298

1029

Growdon

1978

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

Biochemical Pharmacology

143

23

363

Jonsson

1974

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

Biological Psychiatry

146

12

323

Kaiya

1977

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

Molecular Pharmacology

147

9

619

Kalisker

1973

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

American Journal of Psychiatry

5 April 2022

152

130

479

Kazamatsuri

1973

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

Molecular Pharmacology

169

12

639

Krueger

1976

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

208

100

745

Poursines

1959

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

Pharmacological Reviews

235

24

583

Seeman

1972

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

246

100

751

Sigwald

1959

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

Biological Psychiatry

269

12

431

Tarsy

1977

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

Advances in biochemical psychopharmacology

5 April 2022

277

16

193

Ungerstedt

1977

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60636-4

5 April 2022

Identifiers

0 references

1 reference